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An injection and mixing element 
for delivery and monitoring of inhaled  
nitric oxide
Andrew R. Martin1*, Chris Jackson2, Samuel Fromont3, Chloe Pont3, Ira M. Katz3,4 and Georges Caillobotte3
Background
Inhaled nitric oxide (NO) is known to act as a selective pulmonary vasodilator [1, 2], and 
is currently indicated for use in the treatment of hypoxic respiratory failure of the term 
and near-term newborn [3]. Additional use in improving oxygenation in adult patients 
with acute lung injury or acute respiratory distress syndrome [4, 5], and in alleviating 
pulmonary hypertension in both adults and children post cardiac surgery [6, 7], has been 
well-documented. The vast majority of patients receiving inhaled NO do so in the criti-
cal care setting, and are concurrently supported by invasive or noninvasive positive pres-
sure ventilation. As such, devices developed to administer NO to patients must interface 
with the ventilator breathing circuit and coordinate with the breathing cycle. Current 
marketed NO delivery devices do so by injecting source NO-containing nitrogen (800 
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Background: Inhaled nitric oxide (NO) is a selective pulmonary vasodilator used 
primarily in the critical care setting for patients concurrently supported by invasive or 
noninvasive positive pressure ventilation. NO delivery devices interface with ventilator 
breathing circuits to inject NO in proportion with the flow of air/oxygen through the 
circuit, in order to maintain a constant, target concentration of inhaled NO.
Methods: In the present article, a NO injection and mixing element is presented. The 
device borrows from the design of static elements to promote rapid mixing of injected 
NO-containing gas with breathing circuit gases. Bench experiments are reported to 
demonstrate the improved mixing afforded by the injection and mixing element, as 
compared with conventional breathing circuit adapters, for NO injection into breathing 
circuits. Computational fluid dynamics simulations are also presented to illustrate mix-
ing patterns and nitrogen dioxide production within the element.
Results: Over the range of air flow rates and target NO concentrations investigated, 
mixing length, defined as the downstream distance required for NO concentration 
to reach within ±5 % of the target concentration, was as high as 47 cm for the con-
ventional breathing circuit adapters, but did not exceed 7.8 cm for the injection and 
mixing element.
Conclusion: The injection and mixing element has potential to improve ease of use, 
compatibility and safety of inhaled NO administration with mechanical ventilators and 
gas delivery devices.
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parts per million, ppm, NO in balance nitrogen, N2, in North America; 225–1000 ppm 
NO in N2 in Europe) into the inspiratory limb of the breathing circuit. The injection flow 
rate is adjusted in proportion to the flow rate of air/oxygen in the circuit so as to main-
tain a constant, target NO concentration in the inhaled gas mixture. Fittingly, dosing 
recommendations have been established based on the NO concentration in inhaled gas 
[4, 8].
An important function of NO delivery devices is to sample the inhaled gas mixture 
downstream from the point of NO injection so as to establish whether or not target 
NO concentrations are met [9–11]. Sampled gas is also monitored for nitrogen dioxide 
(NO2), a toxic reaction product when NO is in the presence of oxygen. Physical spacing 
between the injection and sampling points is required so that injected NO adequately 
mixes with breathing circuit gases before being sampled [12]. In practice, the injection 
point is positioned close to the ventilator and the sampling point positioned close to 
the patient, so that transit of gases through the inspiratory limb of the breathing cir-
cuit provides ample mixing time. Several drawbacks are associated with this practice. 
First, while increased NO residence time in breathing circuits is beneficial for gas mix-
ing, production of NO2 increases with increased residence time as well. A recent bench 
investigation of NO delivery through neonatal noninvasive respiratory support devices 
measured potentially dangerous NO2 concentrations (>2  ppm) in certain worst-case 
scenarios related to extended gas residence times in breathing circuits [13]. Second, for 
newer, noninvasive forms of respiratory support, such as high flow nasal cannula therapy 
[14, 15], gas delivery conduits may lack sufficient internal volume to ensure mixed sam-
ples, so that modifications are required at the device level to enable compatibility with 
NO delivery. Finally, given the wide range of invasive and noninvasive forms of respira-
tory support currently available in intensive care units, there exists potential for human 
error in placing NO injection and sampling connections at appropriate positions within 
a diverse range of breathing circuits and gas delivery apparatus.
It is therefore desirable to move towards NO injection and sampling apparatuses capa-
ble of safe and effective operation with limited specific restrictions on their positioning 
within breathing circuits. Such apparatuses would serve the dual purpose of ensuring 
ease of setup and compatibility with a wide range of respiratory support devices, while 
permitting NO injection to occur closer to the patient, thereby reducing NO residence 
time in the circuit and associated NO2 production. In the present article, a NO injec-
tion and mixing element is presented. The device borrows from the design of traditional 
static elements to promote rapid mixing of injected NO-containing gas with breathing 
circuit gases. Bench experiments are presented to demonstrate the improved mixing 
afforded by the injection and mixing element as compared with injection through two 
commercially-available breathing circuit adapters used for NO injection with marketed 
NO delivery devices. CFD simulations are also presented to illustrate mixing patterns 
and NO2 production within the element.
Methods
Experimental measurements
Experiments were conducted to determine the downstream distances required to mix 
injected NO-containing gas (800 ppm NO in balance N2; American Air Liquide, USA) 
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into steady flows of air within standard 22 mm breathing circuit tubing and connections. 
Air flow rate was set using a rotameter (FME Series; Western Medica, USA) for flow 
rates between 2 and 10 standard liters per minute (l/min) and a second rotameter (King 
Instrument Company, USA) for 40 l/min flow rates. A 2 m length of straightened breath-
ing circuit tubing was positioned upstream from the point of NO injection. Adapters 
used for NO injection were followed by a series of 16 respiratory gas sampling ports 
(22M–22F with 10 M Swivel Elbow; Intersurgical, UK), as shown schematically in Fig. 1. 
The flow rate of injected NO-containing gas was set using a mass flow controller (MCS-
2SLPM-D/5 M; Alicat Scientific, USA) and was adjusted according to the air flow rate to 
achieve final NO concentrations in the mixed gas of 10, 20 and 40 ppm NO. As depicted 
in Fig. 1, the 16 sampling points were connected via stopcocks such that gas was sam-
pled from a single sampling point at a time to a Sievers 280i NO analyzer (General Elec-
tric; USA). The sampling flow rate was held constant throughout experiments at 200 ml/
min. The NO analyzer was connected via serial communication to a personal computer, 
and a LabView (National Instruments, USA) based virtual instrument was written for 
data acquisition.
For a given experimental run, steady flow rates of air and of NO-containing gas were 
set, and then NO concentration at each sampling point was measured. A sampling inter-
val of 5 s was used at each point, and the average NO concentration over the interval 
was calculated and recorded. Experiments were repeated in triplicate, with rotameter 
and mass flow controller set points reset between repetitions. Measured NO concentra-
tions are reported below as the average ± standard deviation between repetitions. For 
two commercially-available breathing circuit adapters used for NO injection (described 
below), concentration measurements were made both with sampling points at the same 
angular position as the NO injection (i.e. at the top of the main flow conduit, as depicted 
in Fig. 1) and rotated 180° from the NO injection point (i.e. at the bottom of the main 
Fig. 1 Schematic of experimental apparatus used for measuring nitric oxide (NO) concentration downstream 
from injection site. Note that the actual number of sampling ports was 16
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flow conduit). As no significant differences were noted between top and bottom sam-
pling in downstream distance required for NO concentration to reach within ±5 % of 
the final target concentration, further experiments were conducted only with sampling 
points positioned at the top of the flow conduit.
As noted above, two commercially-available breathing circuit adapters were evalu-
ated for NO injection. Both adapters are respiratory gas sampling ports that have been 
repurposed as NO injection ports for use with marketed NO delivery devices. These are 
shown in Fig. 2, and will be referred to below as Adapter A (22M–22F with 10 M Swivel 
Elbow; Intersurgical, UK) and Adapter B (Medical Gas Sampling Straight Connector; 
Smiths, UK). Downstream distances required to achieve final NO concentrations for the 
two adapters were compared to those for the NO injection and mixing element, depicted 
in Figs. 2 and 3. A prototype of the injection and mixing element was designed in Solid-
works (Dassault Systemes, France) and built for testing in R5 Gray resin using an Ultra 
3D printer (EnvisionTEC, USA), with layer thickness of 50 µm and in plane resolution 
of 139 µm. Two versions of the NO injection and mixing element were built and tested: 
the first, as shown in Figs. 2 and 3, included a sudden constriction in internal diameter 
from 22 to 12 mm in the position of NO injection, while the second included no such 
constriction, such that the inner diameter remained at a constant 22 mm from the inlet 
through the injection point.
Fig. 2 Respiratory gas sampling adapters used for nitric oxide injection (top left Adapter A; top right Adapter 
B) along with the injection and mixing element (bottom). Air flow through the adapters and mixing element 
was from right to left
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In addition to NO concentration measurements described above, the pressure drop 
across the adapters, and each version of the injection and mixing element, was evaluated 
using a digital manometer (HD755  ±  0.5 psi range Differential Pressure Manometer; 
Extech Instruments, USA) at the maximum air flow rate studied, 40 l/min.
Computational fluid dynamics simulations
Steady state CFD simulations were performed using the finite volume solver FLUENT 
(ANSYS; USA) for Adapter A and for the injection and mixing element. A laminar 
model of the Navier–Stokes (NS) equations and a transitional turbulence model were 
used for Adapter A and for the injection and mixing element, respectively. Second-
order-accurate discretization schemes were used for all terms. Pressure–velocity cou-
pling was achieved using the SIMPLE algorithm, and the transitional k-kl-ω model, a 
three-equation eddy-viscosity model for laminar and turbulent kinetic energies (k and 
kl, respectively) as well as inverse turbulent time scale (ω), was incorporated. The transi-
tional model is based on two transport equations, one for intermittency and one for the 
transition onset criteria in terms of momentum thickness Reynolds number. The trans-
port equations are intended for the implementation of correlation-based models into 
general-purpose CFD methods [16]. The theoretical framework for the CFD methods, 
including the SIMPLE algorithm and correlation constants for the turbulence model, is 
Fig. 3 a Computer-aided design (CAD) rendering of the injection and mixing element, along with views of b 
the top half and c the bottom half of the element to expose the internal geometry
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provided in the FLUENT Theory Guide [17]. The boundary conditions included no-slip 
and no-penetration at the walls; parabolic laminar velocity profiles (using a user defined 
function) for the air flow and NO injection flow, and the primary outlet boundary was 
given classic outflow conditions forcing downstream velocity derivatives to be zero. The 
CFD simulations included 11 sampling points, each drawing prescribed flow rates of 
18.2 ml/min, for a total flow of 200 ml/min equal to the flow rate through a single port 
during the physical experiment. A mesh refinement study using grids with 2, 4, and over 
9 million cells was performed. The grid with 4 million cells used for this study converged 
to within 0.9 % of the finest grid for flow variables.
The convection, diffusion, and chemical reaction of gaseous species was solved accord-
ing to with the following equation:
where Yi is the mass fraction of NO, NO2, O2, or N2; ρ is the density of the gas mixture; v 
is the fluid velocity; Ri is the net rate of production of species i by chemical reaction; and 
the diffusion flux of species i is expressed as:
where N = 4 is the number of species, Dij is the binary mass diffusion coefficient, com-
puted according to the Chapman-Enskog formula; DT,i is the thermal diffusion coeffi-
cient, and T is temperature.
The CFD simulations additionally included production of NO2, based on the chemical 
reaction:
The rate of reaction was based on the component concentrations and the constant k:
where k was determined using the Arrhenius expression [18]:
where T is the temperature in Kelvin, and k has units of L2/mol2/s.
Results
Experimental measurements
Figures  4 and 5 display NO concentrations measured at sampling points positioned 
at varying distance downstream from the point of NO injection for Adapter A and B, 
respectively. These measurements are displayed for the two versions of the injection and 
mixing element (with and without constriction) in Fig. 6, for air flow rate of 10  l/min. 
For the 2 and 40 l/min air flow rates, both versions of the injection and mixing element 
(1)
∂
∂t
(ρYi)+∇ ·
(
ρ�vYi
)
= −∇ ·
−→
Ji + Ri
(2)
−→
Ji = −
N−1∑
j=1
ρDij∇Yj − DT ,i
∇T
T
(3)2NO+O2 = 2NO2
(4)
d[NO2]
dt
= −
d[NO]
dt
= 2k[NO]2[O2]
(5)k = 1200e530/T
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yielded NO concentration within ±5 % of the final target concentration at all sampling 
locations for all three target concentrations. The mixing length was defined as the down-
stream distance required for NO concentration to reach within ±5 % of the final target 
concentration, and is summarized for the two adapters and the two versions of the injec-
tion and mixing element in Table 1. The pressure drop at 40 l/min measured across each 
adapter or element is also reported in Table 1.
Fig. 4 Normalized NO concentration is plotted against the distance downstream from the point of NO injec-
tion using Adapter A, for air flow rates of 2 l/min (top), 10 l/min (middle), and 40 l/min (bottom)
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Computational fluid dynamics simulations
CFD simulations of NO concentration downstream from injection points were qualita-
tively similar to the experimental measurements, and permit visualization of the mixing 
process inside the adapters and the injection and mixing element. For example, Fig. 7 
compares simulated NO concentrations within Adapter A and the injection and mix-
ing element (with constriction) for the case of 10 l/min air flow and a target 20 ppm NO 
concentration. Similarly, Fig.  8 displays NO concentrations for the injection and mix-
ing element (with constriction) for 10 l/min air flow and for target NO concentration of 
10, 20, and 40 ppm. Simulated NO2 concentrations for 10 l/min air flow and target NO 
concentration of 20 ppm are shown in Fig. 9 for both Adapter A and for the injection 
Fig. 5 Normalized NO concentration is plotted against the distance downstream from the point of NO injec-
tion using Adapter B, for air flow rates of 2 l/min (top), 10 l/min (middle), and 40 l/min (bottom)
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and mixing element (with constriction). For these simulations, the area-weighted aver-
age NO2 concentration at the outlet of the CFD domain was 4.3 ppb for Adapter A and 
2.5 ppb for the injection and mixing element.
Discussion
The present work was conducted in order to explore the design of a novel NO injec-
tion and mixing element for use in ventilator breathing circuits and other breathing gas 
delivery conduits. Experimental results indicate that the downstream distance required 
to achieve complete mixing between injected NO-containing gas and breathing gas (air, 
in the present experiments) was greatly reduced when using the injection and mixing 
element in place of conventional breathing circuit adapters. Indeed, for the final injec-
tion and mixing element design, which included a cross-sectional area constriction at 
the location of NO injection, measured NO concentrations were within ±5 % of final 
target concentrations at the sampling point positioned closest to the element (a distance 
of 7.8 cm from the point of NO injection) in all cases studied. In contrast, for Adapter A, 
a distance of up to 47 ± 7 cm was required downstream of the NO injection point before 
Fig. 6 Normalized NO concentration is plotted against the distance downstream from the point of NO injec-
tion using the injection and mixing element designs with and without constriction in the region of injection. 
The air flow rate is 10 l/min
Table 1 Mixing length and pressure drop for injection apparatus
Values are mean ± standard deviation (n = 3)
a The worst case mixing distances of the three air flow rates and three target NO concentrations are shown
b Worst case mixing occurred for 10 l/min and 10 ppm
c Worst case mixing occurred for 10 l/min and 10 ppm
d Worst case mixing occurred for 10 l/min and 20 ppm
e Indicates that the NO concentration was within 5 % of the final target concentration by the first sampling point for all 
repeated experiments at each combination of air flow rate and target NO concentrion. The distance to the first sampling 
point is indicated
f Pressure drop was evaluated for air flow at 40 l/min
Description Mixing lengtha (cm) Pressure dropf (Pa)
Adapter A 47 ± 7b 2 ± 0
Adapter B 27 ± 1c 44 ± 3
Custom w/out constriction 23 ± 1d 33 ± 2
Custom w/constriction <7.8e 57 ± 5
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measured NO concentrations were within ±5 % of final target concentrations. This latter 
result highlights the importance of instructions provided with current delivery devices 
for positioning NO injection and sampling points at opposing ends of inspiratory tubing. 
Without sufficient mixing between NO injection and sampling, monitored NO and NO2 
concentrations will be inaccurate.
CFD simulations were conducted to explore and visualize NO concentrations 
within the internal volumes of Adapter A and the injection and mixing element (with 
Fig. 7 Simulated NO concentrations are displayed for air flow rate of 10 l/min and target NO concentration 
of 20 ppm for Adapter A (top row) and for the injection and mixing element, with constriction (bottom row)
Fig. 8 Simulated NO concentrations are displayed for air flow rate of 10 l/min through the injection and 
mixing element, with constriction for target NO concentration of 10 ppm (top row), 20 ppm (middle row), and 
40 ppm (bottom row)
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constriction), selected as the worst and best performing devices, respectively, in the 
experimental study. For the injection and mixing element, simulations indicated 
enhanced mixing between the NO-containing gas stream and air stream resulting from 
separation and recombination of the gas mixture along different flow paths through the 
three angled fins positioned immediately downstream from the NO injection point. This 
is similar to the mixing process through traditional static mixing elements used in a 
variety of engineering fields, which contain multiple baffles in series, each similar to the 
three-fin design used at present. For use in breathing circuits, low resistance to flow is 
critical; therefore, a single (non-repeated) mixing element is preferred.
A small additional improvement to mixing afforded by the custom injection and mix-
ing element presented herein resulted from the inclusion of a cross-sectional area con-
striction at the location of NO injection. Without this constriction, the inner diameter 
of the element was 22  mm through the location of NO injection. With the constric-
tion included, the inner diameter was reduced to 12 mm for a short length of 13 mm 
centered on the location of NO injection. It is hypothesized that inclusion of the con-
striction enhanced mixing by increasing local air speeds at the point of injection and 
immediately upstream from the three mixing fins.
The pressure drop measured across the injection and mixing element with cross-
sectional area constriction at the location of NO injection, 57 Pa (or 0.58 cm H2O) at 
40 l/min, was greater than that for the injection and mixing element with no constric-
tion, 33 Pa (0.34 cm H2O) at 40  l/min. However, both were well below pressure levels 
commonly targeted during pressure support or pressure control mechanical ventila-
tion (which may range from ~10 to 40 cm H2O), such that positioning the element in-
line in the inspiratory limb of a ventilator breathing circuit would have minimal effect 
on pressures present in patient airways. Indeed, the pressure drop measured through 
Fig. 9 Simulated NO2 concentrations are displayed for air flow rate of 10 l/min and target NO concentration 
of 20 ppm for Adapter A (top) and the injection and mixing element, with constriction (bottom)
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commercial Adapter B, with a minimum inner diameter similar to that of the injection 
and mixing element with constriction, was of a similar magnitude, 44 Pa (0.45 cm H2O). 
Adapter B is widely used in ventilator breathing circuits, with no reported concerns over 
imposed resistance to ventilator flows.
CFD simulations also estimated NO2 levels produced in Adapter A and the injection 
and mixing element through the reaction of NO with oxygen. In both cases, NO2 con-
centration remained well below 1 ppm, a level associated with the onset of deleterious 
health effects [11]. Despite these low levels for the cases simulated, it is noted that NO2 
production was reduced using the injection and mixing element. This is attributed to 
a reduced time during which high concentrations of NO were in the presence of oxy-
gen, i.e. during incomplete mixing; the rate of NO2 production is proportional with the 
square of NO concentration (Eq. 4, above). Although increasing oxygen concentration 
would yield a proportional increase to the rate of NO2 production, for the constant flow 
rate simulations performed, NO2 levels would remain well below 1  ppm. In contrast, 
during cyclic flow conditions, as occurs in breathing circuits with low or no bias flow, 
the time available for reaction of NO with oxygen between inspiratory cycles is greatly 
increased. Whether or not improved initial mixing of NO-containing and oxygen-con-
taining gas streams can reduce NO2 formation in breathing circuits under cyclic flow 
conditions remains to be studied. In practice, additional and potentially more significant 
reduction in NO2 production would be afforded by positioning the injection and mixing 
element close to the patient, thereby reducing NO residence time in the breathing cir-
cuit. Such a reduction may be important when considering options to guard against NO2 
exposure [13, 19].
The present study demonstrates improved mixing between injected NO-containing 
gas and air flow through breathing circuits for the injection and mixing element as 
compared with Adapters A and B. That said, certain limitations can be discussed. CFD 
simulations reported herein served to illustrate notably different spatial mixing patterns 
between Adapter A, which performed worst in the experimental study, and the injec-
tion and mixing element (with constriction), which performed best in the experimental 
study. Detailed comparison between experimental measurement and CFD simulation 
of NO concentration in gases sampled downstream from the injection point is not pre-
sented. While qualitatively similar NO concentrations were observed, minor differences 
were present between experimental data and CFD simulations. The goal of the present 
work was not to validate CFD simulations for quantitative predictions, but rather to use 
CFD as a tool for visualization of mixing phenomenon, so as to supplement our experi-
mental results. Further, the present experiments were restricted to constant flows of air 
and NO-containing gas. In practice, for many modern mechanical ventilators, gas flow 
through the inspiratory limb of a breathing circuit will vary during the breathing cycle. 
The flow rate of injected NO-containing gas is therefore adjusted in proportion to the 
breathing circuit gas flow, in an attempt to maintain constant NO concentration in the 
mixed gas downstream. Use of the injection and mixing element with time varying flows 
of air, or air/oxygen mixtures, and NO-containing gas remains to be explored. In this 
case, NO concentrations measured downstream from NO injection will again depend 
on mixing that occurs between the injection and sampling points, but also on any 
appreciable time lag between variation in the flow rate of air/oxygen and proportional 
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adjustment of the flow of injected NO-containing gas. Accordingly, the present results 
are most readily applicable to the subclass of ventilators and breathing support devices 
which maintain a constant flow rate of gases supplied to the patient. This includes, for 
example, devices used to administer high flow nasal cannula therapy and constant-flow 
transport ventilators.
Conclusions
In summary, a NO injection and mixing element was described that permits rapid mix-
ing of injected NO-containing gas with breathing circuit gases. Bench experiments dem-
onstrated improved mixing afforded by the injection and mixing element compared with 
conventional breathing circuit adapters. Computational fluid dynamics (CFD) simula-
tions illustrated mixing patterns and NO2 production within the element. The injection 
and mixing element has potential to improve ease of use, compatibility, and safety of 
inhaled NO administration with mechanical ventilators and other gas delivery devices.
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